Growth hormone response to apomorphine, a dopamine receptor agonist, in normal aging and in dementia of the Alzheimer type
- 1 May 1989
- journal article
- research article
- Published by Elsevier in Neurobiology of Aging
- Vol. 10 (3) , 227-231
- https://doi.org/10.1016/0197-4580(89)90055-9
Abstract
No abstract availableThis publication has 40 references indexed in Scilit:
- Characteristic Plasma Hormone Changes in Alzheimer's DiseaseThe British Journal of Psychiatry, 1987
- Hypothalamic pathology in Alzheimer's diseaseNeuroscience Letters, 1987
- Dopaminergic neurotransmitter systems in Alzheimer's disease and in Down's syndrome at middle age.Journal of Neurology, Neurosurgery & Psychiatry, 1987
- Neuron numbers in hypothalamic nuclei in young, middle-aged and aged male ratsCellular and Molecular Life Sciences, 1985
- Changes of Biogenic Amines and Their Metabolites in Postmortem Brains from Patients with Alzheimer‐Type DementiaJournal of Neurochemistry, 1984
- Effect of domperidone on apomorphine-induced growth hormone secretion in normal menJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1982
- Hypothalamic-pituitary dopaminergic function in hepatic failure in manJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1982
- Changes in Neuroendocrine Control of Anterior Pituitary Function during AgingNeuroendocrinology, 1982
- EFFECT OF APOMORPHINE ON HUMAN-GROWTH-HORMONE SECRETIONThe Lancet, 1972
- The effect of administration of human growth hormone on the plasma growth hormone, cortisol, glucose, and free fatty acid response to insulin: evidence for growth hormone autoregulation in manJournal of Clinical Investigation, 1971